TD Asset Management
NAMS icon

TD Asset Management’s NewAmsterdam Pharma NAMS Stock Holding History

TD Asset Management’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.03M Buy
+148,400
New +$4.89M ﹤0.01% 805
2026
Q1 		– Sell
-13,180
Closed -$462K – 1269
2025
Q4 		$462K Sell
13,180
-4,820
-27% -$175K ﹤0.01% 1180
2025
Q3 		$512K Buy
+18,000
New +$431K ﹤0.01% 1171

Other funds holding NAMS

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

TD Asset Management's NAMS Position: Q2 2026 in Review

TD Asset Management opened a new position in NewAmsterdam Pharma (NAMS) in Q2 2026: 148,400 shares worth $5.03M. The stake represents ﹤0.01% of the portfolio and ranks #805 among its holdings. This is a return to the name: TD Asset Management previously reported a position in NAMS as recently as Q4 2025.

TD Asset Management first reported a position in NAMS in Q3 2025 and has held it in 3 quarters since. 111 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • TD Asset Management held 148,400 shares of NewAmsterdam Pharma worth $5.03M as of Q2 2026.
  • NewAmsterdam Pharma was a new TD Asset Management position in Q2 2026.
  • NewAmsterdam Pharma made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #805 holding.
  • TD Asset Management first reported a position in NewAmsterdam Pharma in Q3 2025 and has held it in 3 quarters since.
  • 111 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.